BeyondSpring is trading 8% down at $0.69 after closing at $0.75 on September 15, 2026, with no clear company-specific announcement, earnings release, or regulatory catalyst identified for September 16, 2026.

  • The latest company news includes September 1 clinical presentation materials.
  • Broader U.S. equity futures were modestly higher and did not clearly explain the decline.
  • The move may reflect thin liquidity or continued volatility.